Role of MIC levels and 23S rRNA mutation sites to clarithromycin in 14-day clarithromycin bismuth quadruple therapy for Helicobacter pylori eradication: A prospective trial in Beijing
Author:
Chen Ying,
Li Siyu,
Li Wenbin,
Wang Yiran,
Shi Jihua,
Xu Xue,
Zhang Pan,
Chen Dan,
Gang Rui,
Luo QingfengORCID